Intercure Ltd.
No enriched coverage for $INCR in the last 7 days.
No SEC Form 4 filings for $INCR in the last 30 days.
The Company reports NIS 130 million in revenue and NIS 12 million in positive operating cash flow, demonstrating resilience and sustained profitability with its eleventh consecutive half of positive Adjusted EBITDA amidst ongoing recovery in Israel
InterCure Ltd. INCR revealed on Friday that it will acquire Botanico Ltd., known as ISHI, in a move designed to strengthen its global cannabis portfolio and deliver entry into premium American cultivation technology and brand partnerships.
Acquisition of leading cannabis company marks major milestone in InterCure's commercial expansion strategy, bringing access to premium American brands and state-of-the-art cultivation technologies
